(ASHR) Harvest CSI 300 China - Overview
Etf: China A-Shares, Blue-Chip, Securities, Index
Dividends
| Dividend Yield | 2.34% |
| Yield on Cost 5y | 1.96% |
| Yield CAGR 5y | 21.75% |
| Payout Consistency | 83.6% |
| Payout Ratio | - |
| Risk 5d forecast | |
|---|---|
| Volatility | 19.5% |
| Relative Tail Risk | -14.6% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.37 |
| Alpha | 24.00 |
| Character TTM | |
|---|---|
| Beta | 0.371 |
| Beta Downside | 0.249 |
| Drawdowns 3y | |
|---|---|
| Max DD | 33.12% |
| CAGR/Max DD | 0.15 |
Description: ASHR Harvest CSI 300 China January 14, 2026
The Xtrackers Harvest CSI 300 China A-Shares ETF (ASHR) is required to allocate at least 80 % of its net assets to securities that are constituents of the CSI 300 index, which tracks the 300 largest and most liquid A-share stocks on the Shanghai and Shenzhen exchanges. Because the fund mirrors a concentrated index, it is classified as non-diversified.
Key market drivers that affect ASHR’s performance include the heavy weighting of the financial sector (≈ 40 % of the CSI 300) and consumer discretionary (≈ 20 %), both of which are sensitive to People’s Bank of China policy rates and domestic consumption trends. Recent data (Q4 2025) show the CSI 300’s year-to-date return at +4.2 % versus a 5-year average of +7.5 %, while the ETF’s expense ratio sits at 0.65 %-above the global equity average but typical for China-focused funds. Additionally, the fund’s beta to the Chinese yuan is roughly 0.9, indicating strong currency exposure that can amplify or dampen returns depending on RMB movements.
For a deeper quantitative breakdown of ASHR’s risk-adjusted returns and sector exposure, you might explore the analytics on ValueRay.
What is the price of ASHR shares?
Over the past week, the price has changed by +0.80%, over one month by +3.63%, over three months by +2.47% and over the past year by +32.42%.
Is ASHR a buy, sell or hold?
What are the forecasts/targets for the ASHR price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 37.1 | 9.3% |
ASHR Fundamental Data Overview January 29, 2026
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 1.80b USD (1.80b + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
EV/FCF = unknown (FCF TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 1.80b)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 1.80b / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 7.28% (E(1.80b)/V(1.80b) * Re(7.28%) + (debt-free company))
Discount Rate = 7.28% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Fair Price DCF = unknown (Cash Flow 0.0)